Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,472,905
+$23,861 QoQ
Shares Held
9,737
-2.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#2,169
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CVA Family Office, LLC holds $13,101,368 across 15 Drug Manufacturers - General names. JNJ ranks #2 (18.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,076 | $3,689,446 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
9,737 | $2,472,905 | |
| 3 | AMGN |
Amgen Inc
|
4,049 | $1,466,223 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,140 | $1,431,490 | |
| 5 | ABBV |
AbbVie Inc.
|
4,882 | $1,228,506 | |
| 6 | NVS |
Novartis AG
|
5,542 | $868,542 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,306 | $536,211 | |
| 8 | GSK |
GSK plc
|
8,000 | $419,360 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,472,905 | 9,737 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,449,044 | 10,019 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,880,140 | 9,085 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $1,672,117 | 9,018 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,311,969 | 8,589 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,427,882 | 8,610 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $913,130 | 6,314 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $1,477,338 | 9,116 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $972,987 | 6,657 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $1,275,802 | 8,065 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $1,259,876 | 8,038 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $1,331,351 | 8,548 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $1,242,724 | 7,508 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $1,301,845 | 8,399 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $1,357,378 | 7,684 | Shares | Sole | 2023-02-22 | |
| 2022-09-30 | $1,251,664 | 7,662 | Shares | Sole | 2022-11-22 | |
| 2022-06-30 | $1,255,350 | 7,072 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $1,253,370 | 7,072 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $818,056 | 4,782 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $546,354 | 3,383 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $998,324 | 6,060 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $878,779 | 5,347 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $464,428 | 2,951 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $503,661 | 3,383 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $450,437 | 3,203 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $382,375 | 2,916 | Shares | Sole | 2020-05-28 | |
| No filing history on record for this holder in this stock. | ||||||